0001683168-24-000706.txt : 20240206 0001683168-24-000706.hdr.sgml : 20240206 20240206102739 ACCESSION NUMBER: 0001683168-24-000706 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240201 FILED AS OF DATE: 20240206 DATE AS OF CHANGE: 20240206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Downs Christopher CENTRAL INDEX KEY: 0001705978 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39126 FILM NUMBER: 24598669 MAIL ADDRESS: STREET 1: 31700 RESEARCH PARK DRIVE CITY: MADISON HEIGHTS STATE: MI ZIP: 48071 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CNS Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001729427 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 822318545 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2100 WEST LOOP SOUTH STREET 2: SUITE 900 CITY: HOUSTON STATE: TX ZIP: 77027 BUSINESS PHONE: 1-800-946-9185 MAIL ADDRESS: STREET 1: 2100 WEST LOOP SOUTH STREET 2: SUITE 900 CITY: HOUSTON STATE: TX ZIP: 77027 4 1 ownership.xml X0508 4 2024-02-01 0 0001729427 CNS Pharmaceuticals, Inc. CNSP 0001705978 Downs Christopher C/O CNS PHARMACEUTICALS, INC. 2100 WEST LOOP SOUTH, SUITE 900 HOUSTON TX 77027 0 1 0 0 Chief Financial Officer 0 Common stock 2024-02-01 4 P 0 66666 0.30 A 103438 D Series A Warrant to purchase common stock 0.30 2024-02-01 4 A 0 66666 A 2024-02-01 2029-02-01 Common Stock 66666 94906 D Series B Warrant to purchase common stock 0.30 2024-02-01 4 A 0 66666 A 2024-02-01 2025-10-01 Common Stock 66666 161572 D The common stock, Series A warrants and Series B warrants were acquired by the reporting person in a public offering conducted by the Company that was closed on February 1, 2024. /s/ Christopher Downs 2024-02-05